Diagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut

MT Newswires Live03-30

Hangzhou Diagens Biotechnology (HKG:2526) raised HK$719.8 million in net proceeds from its initial public offering in Hong Kong.

The final offer price was set at HK$99.00 per H-share, according to a Friday after-market filing with the Hong Kong Stock Exchange.

The Chinese biotechnology company offered 8.0 million H-shares in the global offering.

The Hong Kong public offer was 1,073.37 times subscribed, with a final allocation of 799,950 shares, representing 10% of the total offering.

The international offering was 3.45 times subscribed, with a final allocation of 7.2 million shares, or 90% of the total offering.

Diagens Biotechnology is scheduled to debut on the Hong Kong bourse on Monday, March 30.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2623336322?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 06:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623336322","market":"sh","top_or_hot":-1,"title":"Diagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut","media":"MT Newswires Live","content":"<html><body><p> Hangzhou Diagens Biotechnology (HKG:2526) raised HK$719.8 million in net proceeds from its initial public offering in Hong Kong.</p><p>The final offer price was set at HK$99.00 per H-share, according to a Friday after-market filing with the Hong Kong Stock Exchange.</p><p>The Chinese biotechnology company offered 8.0 million H-shares in the global offering.</p><p>The Hong Kong public offer was 1,073.37 times subscribed, with a final allocation of 799,950 shares, representing 10% of the total offering.</p><p>The international offering was 3.45 times subscribed, with a final allocation of 7.2 million shares, or 90% of the total offering.</p><p>Diagens Biotechnology is scheduled to debut on the Hong Kong bourse on Monday, March 30.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Diagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDiagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-30 06:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Hangzhou Diagens Biotechnology (HKG:2526) raised HK$719.8 million in net proceeds from its initial public offering in Hong Kong.</p><p>The final offer price was set at HK$99.00 per H-share, according to a Friday after-market filing with the Hong Kong Stock Exchange.</p><p>The Chinese biotechnology company offered 8.0 million H-shares in the global offering.</p><p>The Hong Kong public offer was 1,073.37 times subscribed, with a final allocation of 799,950 shares, representing 10% of the total offering.</p><p>The international offering was 3.45 times subscribed, with a final allocation of 7.2 million shares, or 90% of the total offering.</p><p>Diagens Biotechnology is scheduled to debut on the Hong Kong bourse on Monday, March 30.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02526","symbol_name":"德适-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2623336322","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2623336322","pubTimestamp":1774822524,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hangzhou Diagens Biotechnology  raised HK$719.8 million in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$99.00 per H-share, according to a Friday after-market filing with the Hong Kong Stock Exchange.The Chinese biotechnology company offered 8.0 million H-shares in the global offering.The Hong Kong public offer was 1,073.37 times subscribed, with a final allocation of 799,950 shares, representing 10% of the total offering.The international offering was 3.45 times subscribed, with a final allocation of 7.2 million shares, or 90% of the total offering.Diagens Biotechnology is scheduled to debut on the Hong Kong bourse on Monday, March 30.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02526":"德适-B"},"translate_title":"Diagens Biotechnology在香港IPO上市前融资7.198亿港元","themeId":"96ef6e519c72e012a7a2848967d28628","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02526":0.9},"content_text":"Hangzhou Diagens Biotechnology (HKG:2526) raised HK$719.8 million in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$99.00 per H-share, according to a Friday after-market filing with the Hong Kong Stock Exchange.The Chinese biotechnology company offered 8.0 million H-shares in the global offering.The Hong Kong public offer was 1,073.37 times subscribed, with a final allocation of 799,950 shares, representing 10% of the total offering.The international offering was 3.45 times subscribed, with a final allocation of 7.2 million shares, or 90% of the total offering.Diagens Biotechnology is scheduled to debut on the Hong Kong bourse on Monday, March 30.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623336322","isCrawlerRequest":true}